Assessment of the serotonin pathway as a therapeutic target for pulmonary hypertension
Blockade of the serotonin reuptake transporter (5-HTT), using fluoxetine, has been identified as a potential therapeutic target for preventing and, importantly, reversing pulmonary hypertension (PH). This study utilized synchrotron radiation microangiography to determine whether fluoxetine could pre...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Journal of synchrotron radiation. - 1994. - 20(2013), Pt 5 vom: 15. Sept., Seite 756-64
|
|---|
| 1. Verfasser: |
Gray, Emily A
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Tsuchimochi, Hirotsugu,
Pearson, James T,
Sonobe, Takashi,
Fujii, Yutaka,
Yoshimoto, Misa,
Umetani, Keiji,
Shirai, Mikiyasu,
Schwenke, Daryl O |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2013
|
|---|
| Zugriff auf das übergeordnete Werk: | Journal of synchrotron radiation
|
|---|
| Schlagworte: | Journal Article
endothelial dysfunction
fluoxetine
monocrotaline
pulmonary hypertension
rarefaction
rat
serotonin
Serotonin Plasma Membrane Transport Proteins
Slc6a4 protein, rat
mehr...
Fluoxetine
01K63SUP8D
Serotonin
333DO1RDJY
Monocrotaline
73077K8HYV
Acetylcholine
N9YNS0M02X |
|---|